Anebulo Pharmaceuticals Files Definitive Proxy Statement
Ticker: ANEB · Form: DEF 14A · Filed: Mar 6, 2025 · CIK: 1815974
| Field | Detail |
|---|---|
| Company | Anebulo Pharmaceuticals, Inc. (ANEB) |
| Form Type | DEF 14A |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, shareholder-meeting
Related Tickers: ANEB
TL;DR
Anebulo Pharma (ANEB) filed its proxy statement for the annual meeting. Vote your shares!
AI Summary
Anebulo Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on March 6, 2025. This filing is related to the company's annual meeting and outlines important information for shareholders regarding the solicitation of proxies. The company is incorporated in Delaware and its fiscal year ends on June 30.
Why It Matters
This filing is crucial for shareholders as it details the agenda for the company's annual meeting and provides information necessary for them to cast their votes on important corporate matters.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Anebulo Pharmaceuticals, Inc. (company) — Registrant
- 0001493152-25-009311 (filing_id) — Accession Number
- 20250306 (date) — Filing Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing details on the matters to be voted upon.
When was this definitive proxy statement filed by Anebulo Pharmaceuticals, Inc.?
Anebulo Pharmaceuticals, Inc. filed this definitive proxy statement on March 6, 2025.
What is the standard industrial classification for Anebulo Pharmaceuticals, Inc.?
The standard industrial classification for Anebulo Pharmaceuticals, Inc. is Pharmaceutical Preparations [2834].
Where is Anebulo Pharmaceuticals, Inc. incorporated?
Anebulo Pharmaceuticals, Inc. is incorporated in Delaware (DE).
What is the business address of Anebulo Pharmaceuticals, Inc.?
The business address of Anebulo Pharmaceuticals, Inc. is 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 6, 2025 regarding Anebulo Pharmaceuticals, Inc. (ANEB).